INTERNATIONAL PATENT: HANGZHOU SOLIPHARMA CO., LTD., 杭州领业医药科技有限公司 FILES APPLICATION FOR "CRYSTAL FORM OF SELECTIVE PARP-1 INHIBITOR HYDROCHLORIDE, PREPARATION METHOD THEREFOR AND USE THEREOF"

GENEVA, July 18 -- HANGZHOU SOLIPHARMA CO., LTD. (260 6th Ave, Bldg 1, 1st F, Baiyang Subdistrict, Qiantang DistrictHangzhou, Zhejiang 310018), 杭州领业医药科技有限公司 (中国浙江省杭州市钱塘区白杨街道6号大街260号1幢1层) filed a patent application (PCT/CN2025/070941) for "CRYSTAL FORM OF SELECTIVE PARP-1 INHIBITOR HYDROCHLORIDE, PREPARATION METHOD THEREFOR AND USE THEREOF" on Jan 07, 2025. With publication no. WO/2025/148856, the details related to the patent application was published on Jul 17, 2025.

Notably, the patent application was submitted...